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An 8-hydroxyquinoline–proline hybrid with
multidrug resistance reversal activity and the
solution chemistry of its half-sandwich
organometallic Ru and Rh complexes†
János P. Mészáros, a,b Jelena M. Poljarević, a,c István Szatmári,d Oszkár Csuvik,d
Ferenc Fülöp,d Norbert Szoboszlai,e Gabriella Spenglerb,f and Éva A. Enyedy *a,b
Herein the design and synthesis of a new 8-hydroxyquinoline derivative, (S)-5-chloro-7-((proline-1-yl)methyl)8-
hydroxyquinoline (HQCl-Pro), with good water solubility and multidrug resistance reversal activity are reported.
In this work the proton dissociation processes of HQCl-Pro and its complex formation with [Rh(η5-C5Me5)
(H2O)3]
2+, [Ru(η6-p-cymene)(H2O)3]2+ and [Ru(η6-toluene)(H2O)3]2+ were investigated by the combined use of
pH-potentiometry, UV-visible spectrometry and 1H NMR spectroscopy. Our results revealed the prominent
solution stability of the complexes in all cases. The lipophilicity of the complexes increased with the chloride ion
concentration, and the complexes showed moderate logD values (−0.8 to +0.4) at pH 7.4 at all tested Cl− con-
centrations. The formation of mixed hydroxido complexes from the aqua complexes was characterized by rela-
tively high pKa values (8.45–9.62 in chloride-free medium). Complexation processes are much slower with the
Ru(η6-arene) triaqua cations than with [Rh(η5-C5Me5)(H2O)3]2+. Both the pKa values and H2O/Cl− exchange con-
stants of the Ru-complexes are lower by 0.5–1.0 orders of magnitude than those of the Rh analogue. Arene
loss (p-cymene and toluene) and oxidation were found in the case of Ru-complexes when an excess of HQCl-
Pro and aromatic (N,N) bidentate ligands was added. The cytotoxicity and antiproliferative effect of HQCl-Pro
and its complexes were assayed in vitro. In contrast to the structurally familiar 8-hydroxyquinoline, HQCl-Pro
and its Rh(η5-C5Me5) complex were somewhat more effective against drug resistant Colo 320 adenocarcinoma
human cells compared to the drug sensitive Colo 205 cells. The Ru- and Rh-complexes showed a similar metal
uptake level after 4 h, while a longer incubation time resulted in higher cellular Rh concentration.
Introduction
During the administration of conventional chemotherapeutic
agents, multidrug resistant (MDR) cancer phenotypes are often
developed manifesting resistance to related and unrelated classes
of compounds, which is one of the major impediments to suc-
cessful treatment.1 The ATP-binding cassette transporter
P-glycoprotein (P-gp, ABCB1) is the most known transmembrane
transporter that is associated with this resistance phenomenon;
however, multidrug resistance protein 1 and 2 (MRP1 and MRP2)
and breast cancer resistance protein (BCRP) also cause an elev-
ated efflux of toxic compounds.1 Potent P-gp inhibitors were
explored for overcoming the MDR (e.g. verapamil and cyclospor-
ine A), although their use is accompanied by undesirable side
effects.1 Szakács et al. reported a group of anticancer compounds
which are more cytotoxic against MDR cancer cells than drug sen-
sitive ones.2 These molecules are not the inhibitors of P-gp, and
their mechanism of action is still not revealed in detail.
8-Hydroxyquinolines were found to be an important family of
MDR-selective compounds. It was shown that the CH2–N subunit
at position 7 plays an important role in the collateral selectivity,
which is present in compounds e.g. NSC1014, NSC297366,
NSC693871 and NSC57969.2 The 8-hydroxyquinoline (HQ)
scaffold itself has the potential for various structural modifi-
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cations including changes due to pharmaceutical purposes.3–5
HQ and its numerous derivatives are well-known compounds and
have been used in analytical chemistry for many decades due to
their simple chemical structure and strong coordination ability to
metal ions. E.g. clioquinol (5-chloro-7-iodo-8-hydroxyquinoline)
was used as an antiprotozoal and antifungal drug; moreover, it
was explored as a treatment for Alzheimer’s and Parkinson’s
diseases.3,5
Compounds with the 8-hydroxyquinoline moiety were also
reported to exhibit anti-inflammatory, antiviral and antiparasi-
tic effects and numerous HQ derivatives with various substitu-
ents have been developed and tested as anticancer agents in
the last few decades.3–5 Among them halogenated compounds
were often found to be more efficient.5,6
Not only 8-hydroxyquinolines but their particular metal
complexes show anticancer activity as well. The most promi-
nent example is the orally active tris(8-hydroxy-quinolato)
gallium(III) (KP46), which is now under clinical trials and was
successfully tested in phase I on renal cancer.7,8
Other examples are the complexes of platinum group
organometallic cations bearing an aromatic ligand in a half-
sandwich configuration (usually p-cymene (p-cym) or 1,2,3,4,5-
pentamethyl-cyclopentadienyl (C5Me5) ligand). The complexes
of these cations usually have various physico-chemical pro-
perties: the low oxidation state of the metal center (e.g. Ru2+)
was stabilized and the lipophilicity was increased by the arene
ligand; their kinetic lability can be associated with the strong
π-donor/acceptor ability of the arene ligand as well.9,10
Moreover, the fine-tuning of the 3D structure and electronic
properties can be easily achieved by functionalization of the
arene or the remaining facial ligands. The interaction with the
chloride content of the medium can change charge and lipo-
philicity. Nevertheless, new reaction pathways with bio-
molecules can be reached, which differ from the ligand–bio-
molecule interactions: e.g. catalysis of GSH oxidation.9 There
are two main types of active complexes: in the first class, a
monodentate ligand binds strongly to the metal centre and the
leaving group(s) is/are present on two other coordination sites.
Widely known examples are the RAPTA complexes where a
strong P-donor, 1,3,5-triaza-7-phosphaadamantane (PTA), is
the monodentate ligand.11 In the other class, the strongly co-
ordinated bidentate ligand occupies two sites, and a leaving
group is bound in a monodentate way. The dissociation of the
latter can be fine-tuned well with the change of donor atoms.
For example, the target biomolecule is switched from DNA to
protein, depending on the nature of the bidentate ligand: (N,
N) or (O,O).12 This field contains a plethora of studied com-
plexes, and an early example is the group of RAED complexes
which are in vivo active compounds showing activity on cispla-
tin-resistant cell lines.13 Though structure–activity relation-
ships have been reported for these complexes, there is still no
organoruthenium containing drug in clinical use.14,15
Half-sandwich organometallic complexes of the (N,O)
donor 8-hydroxyquinolines are also often investigated. The
organo-ruthenium complexes formed with clioquinol and
other halogenated 8-hydroxyquinoline derivatives were studied
thoroughly by Turel et al., and the inhibition of cathepsin B16
and the anticancer,17 antileukaemic18 and antibacterial
effects19 were reported for these compounds. Nitroxoline
(8-hydroxy-5-nitroquinoline) derivatives showed the anti-meta-
static effect, which was improved by coordination to a half-
sandwich Ru(p-cym) cation.20 An earlier study demonstrated
the anticancer and antibacterial activities of the half-sandwich
Rh and Ir complexes of HQ as well.21 These complexes are
characterized by fairly low IC50 values (∼10 μM or less), which
are promising results; however, they suffer from poor water
solubility.6 The limited water solubility is a major problem
encountered with drug formulation since it makes the admin-
istration difficult and might restrain the attainment of the
desired concentration in the blood circulatory system.
Movassaghi et al. introduced a more polar aromatic ligand
(N-acetyl-L-phenylalanine ethyl ester) instead of p-cymene, and
with this modification the solubility could be improved, while
the cytotoxicity remained at the low-micromolar level.22
The hydrophilic nature of the complexes can be increased
via the improved water solubility of the coordinating HQ
derivative by the introduction of polar functional groups.
However, the use of 8-hydroxyquinoline-5-sulfonate with excel-
lent water-solubility caused the loss of the anticancer activity
reported in our previous study.23 Therefore, the lipophilic
nature of the HQ ligand should be optimized very carefully,
and finding the optimal balance between lipophilicity and
water-solubility is a very important endeavour in the develop-
ment of novel anticancer compounds. Therefore, in this work
we aimed to design an HQ–proline hybrid with elevated water
solubility containing the CH2–N subunit at position 7 for the
expected MDR-selectivity. It is also interesting how the coordi-
nation to metal ions has an effect on the cytotoxicity and MDR
selectivity. When the MDR selective ligand 7-(1-piperidinyl-
methyl)-8-hydroxyquinoline (NSC57969) was combined with
organometallic half-sandwich rhodium and ruthenium
cations, the MDR selectivity remained only in the case of the
Rh(η5-C5Me5) complex, while the coordination to Ru(η6-p-cym)
resulted in the loss of this property.23 Herein the synthesis and
solution chemical characterization of a new, water-soluble
derivative of HQ, (S)-5-chloro-7-((proline-1-yl)methyl)8-hydroxy-
quinoline (HQCl-Pro, Scheme 1), is reported. Its complex for-
mation with half-sandwich cations [Rh(η5-C5Me5)(H2O)3]2+, [Ru
(η6-p-cym)(H2O)3]2+ and [Ru(η6-toluene)(H2O)3]2+ (abbreviated
as [Ru(η6-tol)(H2O)3]2+) is also characterized in solution. In
addition, the measurement of the lipophilicity of the com-
pounds depending on the actual chloride ion concentration
was performed: in the different biofluids the concentration of
Scheme 1 Synthetic route for the HQCl-Pro ligand.
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this coordinating ion may change charge and may have
serious effects. The cytotoxicity of HQCl-Pro was monitored in
sensitive and in multidrug resistant cancer cells and the effect
of complexation with the selected organometallic triaqua
cations on the biological activity was assayed as well.
Results and discussion
Synthesis of HQCl-Pro and its complexes
A novel derivative of 5-chloro-8-hydroxyquinoline (HQCl) was
designed with increased water solubility via the incorporation
of the zwitterionic proline amino acid moiety. L-Proline was
attached to the HQCl scaffold at position 7 via a methylene
linker providing the CH2–N subunit that is reported to be
crucial for the MDR reversal activity.2,23 The coupling of HQCl
with L-proline in the presence of formaldehyde via a modified
Mannich reaction was achieved in methanol under reflux con-
ditions (Scheme 1). The formed (S)-5-chloro-7-((proline-1-yl)
methyl)8-hydroxyquinoline (HQCl-Pro) was isolated by crystal-
lization from the cooled reaction mixture.
The half-sandwich organometallic complexes with Rh(η5-
C5Me5), Ru(η6-p-cym) and Ru(η6-tol) were prepared by mixing
the ligand with a half-equivalent amount of the dimeric pre-
cursors [M(arene)Cl2]2 in methanol solution for 1 h at room
temperature, then the solution was concentrated and precipi-
tation was completed with the addition of diethyl ether. The
formed complex was filtered out, washed with n-hexane and
dried. Complexes were collected in good yields (84–90%).
HQCl-Pro and its complexes were characterized by 1H and 13C
NMR spectroscopy (attached proton test (APT)) and electro-
spray ionization mass spectrometry (ESI-MS). Mass spectra
and NMR spectra are shown in the ESI (Fig. S1–S12†). The
NMR spectra showed a double set of peaks in CD3OD, which
can be explained by diastereomer formation (as was found in
ref. 22 for complexes with chiral arene) or the appearance of a
rigid structure (as it appears also in water for deprotonation
vide infra). The differences of the two sets are shown in
Fig. S13† peak-by-peak, projected on the proposed structures
of complexes. The biggest differences are found in positions
14, 6 and 9, which can be connected with the diastereomer for-
mation: in the complex, next to the chiral carbon atom, the Ru
centre and the N of the protonated amino group become
chiral, and these positions (6,9,14) are close to these atoms.
Additionally, the increased solubility and stability of the
ligand and complexes were checked in phosphate buffer at pH =
7.4. All compounds were water-soluble; 10 mM concentration
exceeds the limits of solubility of HQ, HQCl and their complexes.
The compounds were stable for 1 week (not shown), except for
the ligand itself, which showed a new set of peaks in the aliphatic
region in a ∼20% ratio (see Fig. S14†) after 6 days.
Hydrolysis of the organometallic cations and proton
dissociation processes of HQCl-Pro
Knowing the stability constants of a metal complex and proton
dissociation processes of a molecule is necessary to under-
stand the role of different forms of biologically active com-
pounds in the biological environment. It can give information
about the response to pH and explain the active and inactive
forms of a prodrug. In order to describe the solution specia-
tion of the metal complexes, characterization of the hydrolysis
of the organometallic cations and the (de)protonation equili-
brium processes of the ligand is needed under the conditions
used. The hydrolytic behaviour of the selected organometallic
cations ([Rh(η5-C5Me5)(H2O)3]2+, [Ru(η6-p-cym)(H2O)3]2+ and
[Ru(η6-tol)(H2O)3]2+) has been studied in detail previously.24,25
Overall stability constants were reported for the μ-hydroxido
bridged dinuclear species formed24,25 and these constants are
used in this work. According to Buglyó et al., the hydrolysis of
the [Ru(η6-arene)(H2O)3]2+ organometallic cations can be ade-
quately described by the formation of the hydrolysis product
[(Ru(η6-arene))2(μ-OH)3]+ in chloride-free medium (I = 0.20 M
(KNO3)).
25 However, in the case of [Rh(η5-C5Me5)(H2O)3]2+ the
formation of [(Rh(η5-C5Me5))2(μ-OH)2]2+ and [(Rh(η5-
C5Me5))2(μ-OH)3]+ was reported.24 The interaction between the
metal ions and the hapto ligands is strong, and as a result the
release of the aromatic ligands was not detected in the studied
pH range (pH = 0.7–11.5) (only in the case of some compe-
tition reactions vide infra). These organometallic cations are
considered as units and denoted as ‘M(arene)’ hereinafter.
The knowledge of the pKa value of a bioactive compound is
needed not only for speciation studies, but it is also a key para-
meter affecting the pharmacokinetic properties, since with the
pKa values the actual protonation state and charge of the mole-
cule at a given pH can be calculated. In HQCl-Pro the incorpor-
ation of the L-prolinylmethyl substituent results in two
additional dissociable protons besides the quinolinium-NH+
(NqH
+) and the hydroxyl group (Scheme 2) of the HQ scaffold.
N-methyl-L-proline (N-Me-Pro) is structurally similar to this
substituent and it has two pKa values for the carboxylic acid
and amino functions (Table 1).26
In order to characterize the proton dissociation processes
of HQCl-Pro pH-potentiometric, UV-visible (UV-Vis) and 1H
NMR titrations were performed. Although this compound has
four dissociable protons, only two deprotonation processes
could be determined adequately (with acceptable standard
deviation) in the studied pH range by pH-potentiometry. The
assignment of the deprotonation processes to the functional
groups was done by the interpretation of the 1H NMR and
UV-Vis spectral changes (Fig. 1, S15† and Table 1). Notably, HL
denotes the neutral (zwitterionic) form of the ligand.
The most acidic pKa (≪2) of HQCl-Pro belongs to the car-
boxylic group of the prolinyl substituent, which caused shifts
of the peaks only in the aliphatic region of the 1H NMR
spectra (not shown). The deprotonation of the quinolinium
NqH
+ (up to pH 4) and OH (pH 5.5–9.5) groups was ascer-
tained as high-field shifts of all the CH proton peaks (Fig. 1).
The pKa values of these groups are much lower than those of
HQ (see in Table 1) as a consequence of the presence of the
two electron-withdrawing substituents (chlorine and the proto-
nated CH2–NProH
+ moiety). The structurally more related HQCl
suffers from very poor solubility in aqueous medium and we
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could not determine its pKa values accurately enough in pure
water by UV-Vis titrations even at rather low concentrations
(5–10 μM) (see the estimated values in Table 1). Both the
experimentally obtained and the predicted values for HQCl
represent significantly lower values compared to those of HQ
due to the electron withdrawing effect of the chlorine substitu-
ent as it is expected. Based on the pKa values it can be
observed that the prolinyl amino group deprotonates at a
much higher pH than the amino group in N-Me-Pro.
This can be the result of an intramolecular H-bond between
the deprotonated hydroxylate and the NProH
+ moiety
(Scheme 2). A similar hydrogen bond was found in the crystal
structures between the hydroxylate group and a protonated
morpholine or piperidinyl nitrogen in HQ derived Mannich
bases, and these substituents also had a similar effect on the
pKa values.
29
According to the 1H NMR spectra, only the singlet C6H
peak seems to be sensitive to this deprotonation and a high-
field shift was observed at pH > 10. The UV-Vis spectra,
recorded at various pH values (Fig. 2), revealed three deproto-
nation processes. However, only one pKa value could be com-
Scheme 2 Proton dissociation processes of the ligand HQCl-Pro.
Table 1 Proton dissociation constants (Ka) of HQCl-Pro and HQ, HQCl
and N-methyl-L-proline (N-Me-Pro) for comparison. {T = 25.0 °C; I =
0.20 M (KNO3)}
Method
pKa
(COOH)
pKa
(NqH
+)
pKa
(OH)
pKa
(NProH
+)
HQ pH-potentiometry — 4.99a 9.51a —
HQCl Predicted 4.01b 8.37b —
UV-Vis 3.8c 7.6c
N-Me-Pro pH-potentiometry 1.75d — — 10.36d
HQCl-Pro pH-potentiometry — 2.36 ± 0.02 7.76 ± 0.01 >11.5
UV-Vis — — 7.63 ± 0.01 —
1H NMR ≪2 2.22 ± 0.02 7.62 ± 0.01 —
a I = 0.20 M (KCl), taken from ref. 27. b Calculated with Marvin (ref. 28).
c Estimated from the data obtained by UV-Vis titrations, pH = 2.0–11.5
(I = 0.20 M (KNO3)).
d I = 0.10 M (KCl), taken from ref. 26.
Fig. 1 1H NMR spectra of HQCl-Pro recorded at pH = 1.6–11.8 (low-field region). Numbering of the positions and peak assignment is shown on the
central structure. {c(HQCl-Pro) = 480 μM; solvent: 90% H2O/10% D2O; T = 25.0 °C; I = 0.20 M (KNO3)}.
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puted accurately by the deconvolution of the spectra (Table 1)
as in the other two cases the whole deprotonation processes
could not be seen.
On increasing the pH, the first two deprotonation processes
detected in the UV-Vis spectra belong to the NqH
+ and the
hydroxyl groups, since changes in their protonation state have
a considerable effect on the electron density of the aromatic
rings. Thus, their deprotonation results in significant spectral
changes, especially in the case of the hydroxyl moiety, namely
the emerging strong bands in the range 330–430 nm originate
from the more extended conjugated π-electron system in the
deprotonated form. Surprisingly, the deprotonation of the pro-
linyl amino group also affects the spectra; it is accompanied by
a minor bathochromic shift (see changes at pH > 10 in Fig. 2).
Proton dissociation constants determined on the basis of the
UV-Vis spectrophotometric and pH-potentiometric data are in
good agreement with those obtained by the 1H NMR spectro-
scopic studies (Fig. S16† and Table 1).
On the basis of the obtained pKa values, species distri-
bution was calculated at pH 7.4 and 63.5% of the ligand is
present in its neutral form (HL+/−) that has notably a zwitter-
ionic structure. In 36.5% the hydroxyl group is deprotonated
(L−) resulting in the excellent water solubility of the compound
at physiological pH (vide infra lipophilicity characterization).
Complex formation equilibria of HQCl-Pro with [Rh(η5-C5Me5)
(H2O)3]
2+ and [Ru(η6-arene)(H2O)3]2+
Complex formation of the studied half-sandwich organo-
metallic triaqua cations with the HQ-type ligands is simple
(Scheme S1†) as generally only mono complexes are formed.
The HQ-type ligands coordinate in a (N,O−) bidentate mode
based on the crystallographic and solution speciation
studies.6,16–20,23 Firstly, the kinetics of the complex formation
was investigated spectrophotometrically. Based on the spectral
changes in the [Rh(η5-C5Me5)(H2O)3]2+–HQCl-Pro system the
complexation reaction was found to be fairly fast at pH 3.6
(Fig. S17†), while in the case of Ru(η6-arene) complexes it was
much slower, and at least 1 h was needed to reach the equili-
brium as the spectral changes show in Fig. 3.
The 1H NMR spectrum recorded for the [Rh(η5-C5Me5)
(H2O)3]
2+–HQCl-Pro system at pH 2 revealed peaks belonging
only to a metal complex, and neither a free organometallic
triaqua ion nor an unbound ligand was detected (not shown).
It suggests the formation of significantly highly stable com-
Fig. 2 (a) UV-Vis absorption spectra of HQCl-Pro at pH = 1.7–11.4. (b) Absorbance values at 400 nm as a function of pH. The separated deprotona-
tion steps are shown with different symbols (■, ◆, ▲). {c(HQCl-Pro) = 130 μM; I = 0.20 M (KNO3); T = 25.0 °C; ℓ = 1 cm}.
Fig. 3 (a) Time-dependent UV-Vis absorption spectra of the Ru(η6-tol)–HQCl-Pro (1 : 1) system at pH = 3.64 (solid lines). Dotted curves show the
absorption spectra of the triaqua organometallic metal ion (A) and HQCl-Pro ligand (B); the dashed curve shows their additive spectrum (A + B). (b)
Absorbance values at 388 nm as a function of time. {c([Ru(η6-tol)(H2O)3]2+) = c(HQCl-Pro) = 101 μM; pH = 3.65; I = 0.20 M (KNO3); T = 25.0 °C; ℓ =
1 cm}.
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plexes. Even though the ligand has carboxylate and amino
functions that might coordinate to another metal center, there
is no sign of the formation of any dinuclear species based on
the recorded 1H NMR spectra, and only the mono complex [Rh
(η5-C5Me5)(L)(H2O)]+ is formed (where L is the coordinated
form of HQCl-Pro). The Ru(η6-arene) complexes of HQCl-Pro
behaved similarly. Fig. 4 shows the suggested structures for
complexes [M(arene)(L)(H2O)]
+ in water.
However, the formation of the hydrogen bond is not indi-
cated in Fig. 4, which may occur between the coordinated
hydroxylate group and the protonated prolinyl nitrogen
(O−⋯H+N) as it was determined for the Zn(II) complexes of
various 8-hydroxyquinolines.30 A sign of this hydrogen bond
may appear in methanol: the doubling found in the 13C NMR
spectra may belong to the isomers formed after this hydrogen
bond (Fig. S13†); the biggest differences are seen in the posi-
tions, which are close to this suggested hydrogen bond.
In order to determine the stability constants of the [M(arene)
(L)] complexes, the UV-Vis spectra of acidic samples were recorded
(pH = 0.8–2.8) to force the complex dissociation. The spectra
obtained for the [Rh(η5-C5Me5)(H2O)3]2+–HQCl-Pro system were
practically identical in the entire monitored pH range, however
they are significantly different from the spectra of the unbound
organometallic ion and ligand (Fig. 5a). It indicates that the
complex formation is already complete at pH = 0.8, which hin-
dered the calculation of the stability constant, and similarly no
constants could be determined for the Ru(η6-arene) species
(Fig. 5b). However, this approach was successfully used previously
for the Rh(η5-C5Me5) and Ru(η6-p-cym) 8-hydroxyquinolinato com-
plexes.23 In this work a logK [M(arene)(L)] = 16.45 ± 0.02 was
obtained for the complex [Ru(η6-tol)(8-hydroxyquinolinato)(H2O)]+
based on the pH-dependent UV-Vis spectra (pH = 1.2–2.8,
Fig. S18†) for comparison. Notably, this constant is slightly smaller
than that of [Ru(η6-p-cym)(8-hydroxyquinolinato)(H2O)]+.23
Therefore, displacement reactions were performed to deter-
mine the stability constants of these highly stable complexes.
First, ethylenediamine (en) was chosen as a competitor ligand.
It has no absorbance in the 200–800 nm wavelength range,
which makes it an attractive choice for these studies. However,
mixed-ligand complex formation was detected according to the
1H NMR spectra (Fig. S19†) hindering the constant determi-
nation. The peaks belonging to the methyl hydrogens in the
C5Me5 moiety reflect the various chemical environments of the
organometallic fragment. E.g. at an excess of 23 equivalents of
ethylenediamine not only the peaks of binary complexes [Rh
(η5-C5Me5)(en)(H2O)]2+ and [Rh(η5-C5Me5)(L)(H2O)]+ appear (L:
coordinated form of HQCl-Pro), but two unexpected peaks
were also observed, signed with ♠ and ♣ in Fig. S19.† Addition
of chloride ions decreased the ratio of these peaks (38% →
6%), which indicates that the Cl− and ethylenediamine
compete for the third coordination site. Only ternary complex
formation occurred in the case of the [Ru(η6-p-cym)(L)(H2O)]+
complex even at a huge excess (70 equivalents) of ethylenedia-
mine, and at this high c(en)/c(HQCl-Pro) ratio ca. 50% of Ru
(η6-p-cym) is found in the mixed-ligand complex.
Fig. 4 The schematic representation of the mono complexes [M(arene)
(L)(H2O)]
+ formed with HQCl Pro and the various organometallic
cations.
Fig. 5 UV-Vis absorption spectra (solid lines) of the (a) Rh(η5-C5Me5)–HQCl-Pro system at pH = 0.8–2.0 and of the (b) Ru(η6-p-cym)–HQCl–Pro
system at pH = 0.8–2.8. The dotted curve shows the absorption spectrum of the free organometallic cation (A), the dashed curve (B) shows the
spectrum of the free HQCl-Pro ligand and the long dashed curve (A + B) shows their additive spectrum. {c([Rh(η5-C5Me5)(H2O)3]2+) = c(HQCl-Pro, in
Fig. 4a) = 60 μM; c([Ru(η6-p-cym)(H2O)3]2+) = c(HQCl-Pro, in Fig. 4b) = 115 μM; I = 0.20 M (KNO3); T = 25.0 °C; ℓ = 1 cm}.
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In the next step, 2-picolylamine (pin) was selected and
found to be an appropriate competitor in the case of the
rhodium complex. Since pin has an intense ligand band in the
UV region, only the use of 1H NMR spectroscopy was helpful to
determine the speciation. Therefore, 1H NMR spectra were
recorded for the [Rh(η5-C5Me5)(H2O)3]2+–HQCl-Pro–pin ternary
system at various complex-to-pin ratios (Fig. 6a). The spectra
revealed that while the amount of free HQCl-Pro and [Rh(η5-
C5Me5)(pin)(H2O)]
2+ is increasing with the 2-pin excess, the
amount of the [Rh(η5-C5Me5)(L)(H2O)]+ complex is decreasing.
Based on the integrals of the peaks, fractions of the different
compounds were calculated (Fig. 6b) and the stability constant
was determined (Table 2) using the stability constant of [Rh
(η5-C5Me5)(pin)(H2O)]2+ taken from our previous work.31
However, in the case of [Ru(η6-arene)(H2O)3]2+ complexes
the original yellow colour of the samples changed to pink and
the peaks of the coordinated HQCl-Pro, p-cymene and toluene
disappeared in the 1H NMR spectra at an excess of the compe-
titor 2-picolylamine ligand, which can be explained by arene
loss and the probable oxidation of the Ru centre (Fig. S20†).
Thus, determination of the stability constants failed in these
cases.
This side reaction aroused our interest as other competitor
ligands (including e.g. ligands from biofluids) may also cause
arene loss and may affect bioactivity. Therefore, ligand displa-
cement reactions were studied by UV-Vis spectroscopy. First
the effect of HQCl-Pro itself was studied using different con-
ditions. The addition of two equivalents of ligand to the
complex [Ru(η6-p-cym)(L)(H2O)]+ resulted in a too slow reaction
at pH 2 to detect any changes during 1 h (while O2 passed
through the solution). On the other hand, considerable
changes of the spectra can be seen at physiological pH in
Fig. 7a. The shape of the spectrum changes markedly, and a
strong band developed at 420 nm, which is most probably
related to the loss of the arene ligand and binding of the
second and third HQCl-Pro. The rising broad band at higher
wavelengths (λ > 500 nm) directly indicates the presence of the
Ru(III) compound as it was found for [Ru(III)(8-hydroxyquino-
late)3].
32 Thus the change at 640 nm provides information
about the rate of the Ru(III) complex formation (see Fig. 7b). In
the literature the loss of arene (benzene, p-cymene) and the
formation of [Ru(III)(L)3] were also found in the case of
8-hydroxyquinoline.23,32 As competitor ligands, deferiprone
(1,2-dimethyl-3-hydroxy-pyridin-4(1H)-one) as an (O,O) model
and 1,10-phenanthroline (phen) as a representative of (N,N)
bidentate ligands were chosen. Addition of deferiprone to the
complex [Ru(η6-p-cym)(L)(H2O)]+ did not result in spectral
changes, while the reaction with phen was undoubtedly fast,
and there was a significant difference between the initial solu-
tion (see the additive spectrum) and the spectrum recorded
after 7 s for the mixed reactants (Fig. S21†). The yellow solu-
tion turned red and a strong band developed with λmax =
502 nm. After the first reaction step seemed to be completed
in ∼90 s, another process started at ∼150 s and the main band
shifted to 440 nm. The sign of a tiny amount of Ru(III) was also
Fig. 6 (a) 1H NMR spectra of the [Rh(η5-C5Me5)(L)(H2O)]+–2-picolyla-
mine system recorded at various c(pin)/c(HQCl-Pro) ratios (L is the co-
ordinated form of HQCl-Pro). The aromatic region (with increased
intensity) and C5Me5 methyl protons are shown. Assignment: ◆ = [Rh
(η5-C5Me5)(L)(H2O)]+; ♥ = [Rh(η5-C5Me5)(pin)(H2O)]+. (b) Fitted (solid
line) and measured bound HQCl-Pro ratio values calculated from the
integrals of HQCl-Pro (●) and C5Me5 (▲). {c([Rh(η5-C5Me5)(L)(H2O)]+) =
100 μM; c(pin) = 0.104–1.520 mM; solvent: 90% H2O/10% D2O; pH =
5.91 (20 mM phosphate buffer); T = 25.0 °C; I = 0.20 M (KNO3)}.
Table 2 Stability (K[M(arene)(L)]), proton dissociation (Ka[M(arene)(L)])
and water-chloride exchange constants (K’(H2O/Cl
−)) of complexes of
HQCl-Pro. {T = 25.0 °C; I = 0.20 M (KNO3)}
Ru(η6-p-cym) Ru(η6-tol) Rh(η5-C5Me5)
log K [M(arene)(L)] — — 13.41 ± 0.02a
pKa [M(arene)(L)]
b 8.62 ± 0.04 8.45 ± 0.03 9.62 ± 0.04
log K′ (H2O/Cl
−)c 1.21 ± 0.01 1.09 ± 0.01 1.57 ± 0.01
a For the [Rh(η5-C5Me5)(L)(H2O)]2+ + pin ⇌ [Rh(η5-C5Me5)(pin)(H2O)]2+
+ L equilibrium determined at various c(pin) concentrations by 1H
NMR spectroscopy. bDetermined by UV-Vis spectroscopy at pH
2.0–11.5. c pH = 5.50 (phosphate buffer). For the [M(arene)(L)(H2O)]
+ +
Cl− ⇌ [M(arene)(L)Cl] + H2O equilibrium determined at various total
chloride ion concentrations by UV-Vis spectrophotometry.
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observed at higher wavelengths (A(690 nm) ∼ 0.05). When this
experiment was repeated under argon, similar spectral
changes were observed; however, the formation of Ru(III) could
be successfully avoided. To explain the two main processes,
the experiment was repeated with only 1 equiv. of phen under
aerobic conditions (Fig. S22a†). The first step accompanied by
the development of a band with 502 nm maximum was similar
and was completed within 7 min (Fig. S22b†). Although the
second process was different, most probably oxidation took
place as the development of the strong band at 694 nm indi-
cates (Fig. S22c†). Based on these findings the first step is
most probably the loss of p-cymene and the formation of the
mixed-ligand complex [Ru(II)(phen)(L)(H2O)2]
+ (λmax = 502 nm,
shown in gray rhombuses in Fig. S21b, S22b and c†). This is
followed by the slow coordination of the second phen forming
[Ru(II)(phen)2(L)]
+ when 2 equiv. of phen were provided, while
the slow oxidation occurs without the second phen ligand
forming [Ru(III)(phen)(L)(H2O)2]
2+ (shown in orange squares in
Fig. S21b, S22b and c†).
Reactions of [Ru(η6-p-cym)(L)(H2O)]+ with various bio-
molecules were tested as well. Addition of histidine (His),
human serum albumin (HSA) and RPMI 1640 medium com-
ponents resulted in similar spectral changes (Fig. S23a, c and
e†). We concluded that no Ru(III) was present in the systems,
and most probably a mixed-ligand complex ([Ru(η6-p-cym)(L)
(His)]+) is formed in the presence of histidine and the RPMI
1640 medium components (vide infra for NMR spectra).
Albumin is also able to bind the complex most probably
through its side chains in a monodentate fashion due to the
coordination of a histidine nitrogen, or cysteine thiolate or
methionine thioether.33,34 The reaction with HSA was some-
what slower under the same experimental setup (Fig. S23b, d
and f†).
Based on these findings the following can be concluded: (i)
the excess of rigid (O,O) donor bidentate ligands cannot cause
the loss of p-cymene; (ii) the excess of the rigid 8-hydroxyqui-
nolate-type (N,O−) and rigid (N,N) donor bidentate ligands can
cause liberation of the arene ligand followed by oxidation to
Ru(III) at physiological pH in the presence of O2; (iii) the flex-
ible (N,N) donor ethylenediamine and biologically available
molecules (like histidine, amino acids of RPMI 1640 or human
serum albumin) can readily react with the complex [Ru(η6-p-
cym)(L)(H2O)]
+ forming mixed-ligand complexes. A previously
described class of half-sandwich complexes containing azopyr-
idine ligands also showed arene-loss (even at 1 : 1 metal-to-
ligand ratio), which was explained with the π-acceptor pro-
perties of the bidentate ligand35 as the stronger π-acceptor
bidentate ligands can compete with the arene.
Deprotonation of the coordinated water molecule and its
exchange to the chloride ion in the [M(arene)(L)(H2O)]
+
complexes
In the [M(arene)(L)(H2O)]
+ complexes (L: the coordinated form
of HQCl-Pro) the coordinated aqua ligand can get deproto-
nated with increasing pH and this process is reported to have
an effect on the reactivity of the complex.36 Namely, the hydro-
xido ligand is considered as a worse leaving group than the
water molecule or chloride ion, preventing the complex from
interacting with biomolecules. To determine the pKa values
1H
NMR spectra of the complexes were recorded in a wide pH
range and representative spectra are shown for the titration of
the [Ru(η6-p-cym)(L)(H2O)]+ complex in Fig. 8 (and the spectra
of the Ru(η6-tol) and Rh(η5-C5Me5) complexes are shown in
Fig. S24 and S25†). These spectra reveal that peaks are shifted
at pH > 6, and the chemical shifts draw a sigmoid curve as a
function of pH (Fig. 8c).
From these sigmoid curves pKa [M(arene)(L)] values were
determined (Table 2), which are much lower for the Ru con-
taining complexes than for the Rh-complex. Notably, following
the deprotonation the forming hydroxido complex exhibits
more peaks than the aqua complex. Most probably the depro-
tonation leads to the loss of the twofold symmetry of the
p-cymene ligand and peaks are doubled. Due to the rigid struc-
ture the rotation of the p-cymene ligand is blocked most likely.
Earlier, computational studies revealed that the rotation has a
very low energy barrier in the ruthenium–arene complexes
bearing 1,2-ethylenediamine (RAED), e.g. benzene completes a
Fig. 7 Time-dependent UV-Vis absorption spectra of the [Ru(η6-p-
cym)(L)(H2O)]
+–HQCl-Pro (1 : 2) system at pH = 7.40 in the presence of
O2 (L: the coordinated form of HQCl-Pro). The dashed curve shows the
additive spectrum of the metal complex and 2 equivalents of the HQCl-
Pro ligand. The inserted figure shows absorbance values at 640 nm as a
function of time. {c([Ru(η6-p-cym)(L)(H2O)]+) = 200 μM; c(HQCl-Pro) =
400 μM; pH = 7.40 (20 mM phosphate); c(KCl) = 0.10 M; T = 25.0 °C; ℓ
= 1 cm}.
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full rotation in 2 ps.37 In that case, a steric interaction between
HQCl-Pro, OH− and p-cymene can increase this rotational
barrier.
Using the pKa [M(arene)(L)] values the ratio of the hydro-
xido form of the complexes was calculated at physiological pH
revealing the formation of [M(arene)(L)(OH)] in 6% for Ru(η6-
p-cym), 8% for Ru(η6-tol) and less than 1% for the Rh(η5-
C5Me5)-complex in the absence of chloride ions. pKa of this
type of complexes increases with the chloride ion
concentration,24,38 thus these percentages are merely
maximum values. When the organometallic fragments are
compared with each other, the same trend of the pKa values
was observed for complexes of (N,O) ligands such as 2-picoli-
nates, HQ-5-sulfonate (HQS), HQ and 7-(1-piperidinylmethyl)-
HQ (PHQ)23,38–40 as Fig. 9 shows.
Based on the logK and pKa [M(arene)(L)] constants (Table 2)
concentration distribution curves were calculated for the Rh(η5-
C5Me5) complex of HQCl-Pro (Fig. 10a). A very small amount
(<3%) of free organometallic ions appears at pH 2, while the for-
mation of the [Rh(η5-C5Me5)(L)(H2O)]+ complex is predominant at
pH 7.4. The stability constants determined for the complexes of
HQ derivatives cannot be compared directly due to the different
basicity of ligands. For comparison, pM* (the negative logarithm
of the unbound metal ion) values were calculated and plotted
against the pH (Fig. 10b). (pM* is calculated by taking into con-
sideration the hydrolyzed forms: pM* = −log([M(arene)] +
2×[(M(arene))2(OH)2] + 2×[(M(arene))2(OH)3]). The higher pM*
value indicates higher stability of the complex. In these calcu-
lations, stability constants of the half-sandwich rhodium com-
plexes with HQ, 8-hydroxyquinoline-5-sulfonate and 7-(1-piperidi-
nyl-methyl)-8-hydroxyquinoline were used.23 Although the HQCl-
Pro complex has the highest stability among the others up to pH
∼3.5, at physiological pH the other complexes have somewhat
higher stability.
Adding chloride ions to the solutions of the complexes
causes changes in their 1H NMR and UV-Vis spectra. This is
the result of a third equilibrium process, shown in
Scheme S1,† which is the exchange of the coordinated water
molecule to a chloride ion. Half-sandwich organorhodium and
ruthenium complexes have a relatively high chloride ion
affinity, and the chlorinated forms of the HQCl-Pro complexes
are charge neutral. The chloride content of the medium has
an effect on not only the charge, but also on the pKa [M(arene)
(L)]24,38 and on the lipophilicity.39,41 This affinity is well
described by the log K′ (H2O/Cl
−) constant, which is deter-
mined from the UV-Vis spectra of the complexes by varying the
total concentrations of chloride ions (Fig. S27–S30† and
Table 2).
The log K′ (H2O/Cl
−) constants show that the Rh(η5-C5Me5)
complex has the highest, while [Ru(η6-tol)(L)(H2O)]+ has the
lowest value (Table 2). The constants for [Ru(η6-arene)(L)
(H2O)]
+ complexes have tiny differences, and a similar trend
was found previously in the case of 8-hydroxyquinoline, and
Fig. 8 1H NMR spectra of the Ru(η6-p-cym)–HQCl-Pro 1 : 1 system recorded at pH = 5.6–10.9. (a) Aromatic protons; (b) p-cymene methyl protons.
(c) Measured (◆) and fitted (solid line) chemical shift values of one of the protons on the p-cymene ring as a function of pH. {c([Ru(η6-p-cym)
(H2O)3]
2+) = c(HQCl-Pro) = 300 μM; solvent: 90% H2O/10% D2O; T = 25.0 °C; I = 0.20 M (KNO3)}.
Fig. 9 Comparison of pKa[M(arene)(L)] constants for the half-sandwich
Ru- and Rh-complexes of (N,O) bidentate ligands (I = 0.20 M KNO3).
HL = pic (2-picolinic acid),38–40,a HQ (8-hydroxyquinoline),23,b HQS
(8-hydroxyquinoline-5-sulfonate),23 PHQ (7-(1piperidinylmethyl)-8-
hydroxyquinoline)23 and HQCl-Pro. aI = 0.20 M KCl; bpKa([Ru(η6-tol)(8-
hydroxyquinolinato)(H2O)]
+) = 8.94(2) determined by UV-Vis spectro-
photometric titration in this work, see Fig. S26.†
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Fig. S31† shows this tendency.23 The concentration of the
chloride ion is around 100 mM in blood 24 mM in the cyto-
plasm and 4 mM in the nucleus,42 and the actual concen-
tration affects the ratio of the chloride and aqua complexes
(Fig. 11). The lower the c(Cl−), the higher fraction of the aqua
complex. According to the proposed activation mechanism by
aquation42 the complexes are in their neutral (zwitterionic)
chlorinated form in the blood serum at 100 mM chloride con-
centration. The neutral chlorinated form may penetrate more
easily through the cell membranes and might be trapped in
the cytosol due to the lower chloride concentration and for-
mation of charged aqua forms. While 79% of the rhodium
complex is in the neutral form when the c(Cl−) is 100 mM, it
drops to 47% and 13% at 24 mM and 4 mM chloride ion con-
centrations, respectively (Fig. 11). The Ru(η6-arene) complexes
show somewhat weaker chloride ion affinity.
Chloride concentration-dependence of the lipophilicity of
HQCl-Pro and its complexes
The conventional shake-flask method was used to determine
the chloride-dependent lipophilicity of the ligand and its three
organometallic complexes at physiological pH. Compounds
were dissolved in 20 mM phosphate buffer (pH = 7.4, saturated
with n-octanol), then mixed with n-octanol (saturated with the
aqueous buffer). The buffers contained chloride ions in
different concentrations related to the different biofluids (4,
24, 100 mM). Distribution coefficients (logD7.4) calculated
from UV-Vis quantitative analysis are shown in Fig. 12. The
ligand lipophilicity slightly decreases with increasing chloride
ion concentration, which is the result of the stronger ioniza-
tion effect at higher ionic strength.
The actual chemical form of the studied organometallic
complexes strongly depends on the chloride ion affinity and
concentration, as was described previously. Fig. 11 clarifies the
ratios of the neutral chlorinated and the positively charged
aquated forms at pH 7.4. Based on the data in Fig. 12 it can be
concluded that the most lipophilic complex is [Ru(η6-p-cym)(L)
(H2O/Cl)]
+/0 at 100 mM of Cl−, and the most hydrophilic is [Ru
(η6-tol)(L)(H2O/Cl)]+/0 at 4–24 mM of Cl−. Here the trend of
lipophilicity is different from the trend of the log K′ (H2O/Cl
−)
values: Ru(η6-tol) < Rh(η5-C5Me5) < Ru(η6-p-cym). Although the
rhodium complex has the highest chloride ion affinity, other
factors also affect the lipophilicity such as the higher charge of
the Rh-center (+3) (vs. the +2 charge of Ru) and the negative
charge of the C5Me5 ligand (vs. neutral toluene/p-cymene).
In vitro cytotoxicity and antiproliferative activity
measurements of HQCl-Pro and its complexes on cancer cell
lines
In order to characterize the anticancer effect of HQCl-Pro and
to monitor whether the complexation with organometallic
triaqua cations can affect the cytotoxic activity of the ligand
Fig. 10 (a) Calculated concentration distribution curves of the [Rh(η5-C5Me5)(H2O)3]2+–HQCl-Pro system based on the stability constants from
Table 2. (b) Calculated pM* curves of the Rh(η5-C5Me5)–HQ (-·-),23 8-hydroxyquinoline-5-sulfonate (–),23 7-(1-piperidinylmethyl)-8-hydroxyquino-
line (-··-)23 and HQCl-Pro systems (solid line), pM* = −log([M(arene)] + 2 × [(M(arene))2(OH)2] + 2 × [(M(arene))2(OH)3]). {c([Rh(η5-C5Me5)(H2O)3]2+) =
c(HQCl-Pro) = 50 µM; T = 25.0 °C; I = 0.20 M (KNO3)}.
Fig. 11 The calculated ratio of aquated ([M(arene)(L)(H2O)]
+) (white)
and chlorinated ([M(arene)(L)Cl]) (gray) forms of the HQCl-Pro com-
plexes at different chloride concentrations of modelling biofluids, based
on the constants in Table 2. {c([M(arene)(H2O)3]
2+) = c(HQCl-Pro) =
100 µM; c(Cl−) = 4, 24 and 100 mM; T = 25.0 °C}.
Paper Dalton Transactions
7986 | Dalton Trans., 2020, 49, 7977–7992 This journal is © The Royal Society of Chemistry 2020
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
4 
M
ay
 2
02
0.
 D
ow
nl
oa
de
d 
on
 9
/9
/2
02
0 
8:
21
:4
2 
A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
itself, thiazolyl blue tetrazolium bromide (MTT) assays were
performed in two human colonic adenocarcinoma cell lines
under two kinds of setup. Colo 205 is a drug sensitive cell line,
while Colo 320 is multidrug resistant being primarily mediated
by the overexpression of P-gp. Earlier studies showed that the
reference compound HQ and its organometallic Ru- and Rh-
complexes are cytotoxic in MES-SA and MES-SA/Dx5 cancer cell
lines (IC50 = 1–13 μM).23 The structurally related 7-(1-piperidi-
nylmethyl)-8-hydroxyquinoline and its complexes were found
to be cytotoxic (IC50 = 0.6–20 μM), however the ligand and its
Rh(η5-C5Me5) complex showed collateral sensitivity (with
selectivity ratios 5.8 and 5.1, respectively).
Inhibiting the proliferation and causing cell death may
occur at the same time when the drug is administered to the
cells. Using a lower number of cells per well (6 × 103) and a
longer incubation time (72 h) the MTT assay provides more
information about the activity of the complexes to inhibit cell
proliferation rather than growth inhibition. On the other
hand, in the case of a higher number of cells per well (6 × 104)
and a shorter exposure time (24 h) it is possible to monitor
preferably the cytotoxic effect. IC50 values collected for HQCl-
Pro in the absence and in the presence of [Rh(η5-C5Me5)
(H2O)3]
2+, [Ru(η6-p-cym)(H2O)3]2+ and [Ru(η6-tol)(H2O)3]2+ and
for the precursor dimers [M(η5/6-arene)(μ-Cl)Cl]2 are shown in
Table 3. Doxorubicin and cisplatin were used as positive
controls.
The organometallic precursors have no toxic effect on
cancer cell lines (IC50 > 100 μM). HQCl-Pro and its Rh(η5-
C5Me5) complex exhibited similar and relatively low IC50
values, while in the presence of Ru(η6-tol) and especially Ru
(η6-p-cym) much higher values were obtained. Additionally,
HQCl-Pro and its Rh(η5-C5Me5) complex showed higher anti-
cancer activity in Colo 320 than in Colo 205. In
contrast the toluene and p-cymene complexes have similar
cytotoxicity in both cell lines and the antiproliferative effect is
weaker in the Colo 320 cells. These data do not correlate with
the lipophilicity of the complexes, suggesting that other
factors seem to be more dominant in the bioactivity. Notably,
the complexes have similar or weaker cytotoxicity compared to
cisplatin.
Reaction with cell culture medium components
To find an answer to the decreased activity of the Ru(η6-p-cym)
complex interaction of the complex [Ru(η6-p-cym)(L)(H2O)]+
with the RPMI 1640 cell culture medium was also investigated
by 1H NMR spectroscopy (Fig. 13). Previously we described the
interaction (vide supra for kinetics), which was followed spec-
trophotometrically and no oxidation was detected; only mixed
ligand complex formation was observed. This medium con-
tains various amino acids and other small biomolecules which
may coordinate to the metal center leading to e.g. the (partial)
release of the original ligand or the formation of mixed ligand
species. According to the recorded 1H NMR spectra the free
HQCl-Pro has different spectra in RPMI 1640 medium and in
PBS′ (Fig. 13(3 and 4)); namely the shape of doublets are
blurry, only the envelope type peak can be seen and peaks are
Fig. 12 n-Octanol/water distribution coefficients at pH = 7.4 (logD7.4)
for complexes [Ru(η6-tol)(L)(H2O)]+, [Ru(η6-p-cym)(L)(H2O)]+, [Rh(η5-
C5Me5)(L)(H2O)]
+ and the ligand HQCl-Pro at different chloride ion con-
centrations: 4 mM (black), 24 mM (white) and 100 mM (checkered). {c-
(compounds) = 200 µM; pH = 7.40 (20 mM phosphate buffer); T =
25.0 °C}.
Table 3 In vitro antiproliferative (72 h) and cytotoxic effects (24 h) (IC50 values in μM) of HQCl-Pro and its complexes in addition to the organo-
metallic precursors in sensitive (Colo 205) and multidrug resistant (Colo 320) human colonic adenocarcinoma cell lines
Antiproliferative effect Cytotoxic effect
Colo 205 Colo 320 Colo 205 Colo 320
HQCl-Pro 23.4 ± 3.3 8.5 ± 1.7 42.5 ± 7.4 17.4 ± 2.5
[Ru(η6-tol)(L)(H2O)]+ 25.3 ± 3.1 85.0± 7.5 72.6 ± 4.8 60.9 ± 8.2
[Ru(η6-p-cym)(L)(H2O)]+ 68.3 ± 10.7 >100 >100 >100
[Rh(η5-C5Me5)(L)(H2O)]+ 25.8 ± 4.8 9.7 ± 1.1 81.5 ± 3.3 24.1 ± 3.7
[Ru(η6-p-cym)(μ-Cl)Cl]2 >100 >100 >100 >100
[Ru(η6-tol)(μ-Cl)Cl]2 >100 >100 >100 >100
[Rh(η5-C5Me5)(μ-Cl)Cl]2 >100 >100 >100 >100
Doxorubicin 3.28 ± 0.22 3.12 ± 0.27 1.56 ± 0.03 6.45 ± 0.19
Cisplatin 10.1 ± 0.3 4.78 ± 0.11 83.9 ± 3.5a 18.1 ± 0.3a
a 1 × 104 cells were used for cisplatin.
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shifted slightly due to the presence of the medium com-
ponents. The Mg(II) content of the RPMI 1640 medium is rela-
tively high (∼400 μM) and can explain the observed phenom-
ena since 8-hydroxyquinolines are able to form complexes with
this metal ion. Using stability constants reported for the Mg(II)
complex of 8-hydroxyquinoline-5-sulfonate43 we estimated the
amount of the possibly formed Mg(II) complex under the
experimental conditions. It is suggested that ∼30% of the
ligand can be bound to Mg(II).
For the Mg(II) and Ca(II) complexes of the structurally closer
HQCl stability constants were determined in a 60% (v/v)
dioxane/water mixture,44 and based on these stability con-
stants the bound fraction of the ligand can be ∼60%.
Therefore, peak shifting of the ligand HQCl-Pro can be
explained by the fast exchange between the free ligand and the
Mg(II)/Ca(II) complexes. However, the competition of Ca2+ and
Mg2+ with half-sandwich cations does not occur because the
stability of the latter complexes is much higher. Peaks of
different amino acid components are shown in the medium
(Fig. 13). The singlets of histidine at δ = 7.0 and 7.7 ppm suffer
from the most important change, as they disappeared/shifted
after reacting with the complex [Ru(η6-p-cym)(L)(H2O)]+. This
interaction is most probably the formation of a mixed-ligand
species, and can also affect the final biological activity. In all,
instead of the ligand displacement only the ternary complex
formation with histidine is the most probable interaction, and
there is no sign of ligand release (no free HQCl-Pro or in the
form of the Mg(II) complex). It can be concluded that the
reduced biological activity is most likely not connected to a
dissociation process of the original complexes (at least not in
the medium).
Cellular uptake of complexes
For the sake of better understanding of the difference in the
anticancer activity of the complexes, cellular metal uptake was
also measured with total-reflection X-ray fluorescence (TXRF)
on the cultures of Colo 205 cancer cells. These cells were incu-
bated for 4 and 24 h with the [Ru(η6-p-cym)(L)(H2O)]+ and [Rh
(η5-C5Me5)(L)(H2O)]+ at 200 μM concentration. The effect of
using fetal bovine serum (FBS) in the cell culture medium was
also investigated. As shown in Fig. 14, both complexes were
taken up by cells to a similar extent after 4 h independent of
the medium’s FBS content. After 24 h, the degree of Rh
accumulation in the cells shows a noticeable increase above
400 ng per 106 cells, while the Ru content stays at the same
level after 4 h. This result is in contrast to the lipophilicity
measurement, where [Ru(η6-p-cym)(L)(H2O)]+ was more lipo-
philic; active transport might be more important in the trans-
port of these complexes. The higher concentration of the Rh-
compound inside the cell may explain the difference in the
anticancer activity.
Experimental
Chemicals
All solvents were of analytical grade and used without further
purification. 8-Hydroxyquinoline, 5-chloro-8-hydroxyquinoline,
L-proline, paraformaldehyde, [Rh(η5-C5Me5)(μ-Cl)Cl]2, [Ru(η6-
p-cym)(μ-Cl)Cl]2, 1-methyl-1,4-cyclohexadiene, RuCl3 × 3H2O,
ethylenediamine, 2-picolylamine, 1,2-dimethyl-3-hydroxy-
pyridin-4(1H)-one (deferiprone), 1,10-phenanthroline, doxo-
rubicin, n-octanol, KCl, AgNO3, HNO3, KOH, 4,4-dimethyl-4-
Fig. 13 Monitoring of the interaction between HQCl-Pro, [Ru(η6-p-cym)(L)(H2O)]+ (L: coordinated form of HQCl-Pro) and RPMI 1640 medium com-
ponents by 1H NMR spectroscopy. (a) Aromatic region; (b) aliphatic region. 1: [Ru(η6-p-cym)(L)(H2O)]+ in RPMI 1640; 2: [Ru(η6-p-cym)(L)(H2O)]+ in
PBS’ buffer; 3: HQCl-Pro in RPMI 1640 medium; 4: HQCl-Pro in PBS’ buffer; 5: RPMI 1640 medium. Rectangles show signals due to the interactions:
peaks of histidine (solid line), peaks of HQCl-Pro (dotted line), and peaks of p-cymene methyl groups (dashed line). {c([Ru(η6-p-cym)(H2O)3]2+) =
c(HQCl-Pro) = 100 µM; solvent: 90% H2O/10% D2O; pH = 7.40 (phosphate buffer); T = 25.0 °C; t = 24 h}.
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silapentane-1-sulfonic acid (DSS), RPMI 1640, NaH2PO4,
Na2HPO4 and KH2PO4 were purchased from Sigma-Aldrich in
pure quality, and cisplatin was a TEVA product. Ultrapure
Milli-Q water was used for sample preparation. [Ru(II)(η6-tol)
(μ-Cl)Cl]2 was prepared according to literature procedures.45
The preparation of solutions and the determination of the
concentration of stock solutions were performed as in our
former works,23,24 see the ESI†/pH-potentiometry part for
more information.
The buffered samples were prepared in 20 mM phosphate
buffer or in a modified phosphate buffered saline (PBS′) at pH
7.40. PBS′ contains 12 mM Na2HPO4, 3 mM KH2PO4, 1.5 mM
KCl and 100.5 mM NaCl; and the concentration of the K+, Na+
and Cl− ions corresponds to that of the human blood serum.
Synthesis and characterization of HQCl-Pro and its complexes
Synthesis of compound HQCl-Pro. L-Proline (0.63 g,
5.51 mmol), 5-chloro-8-hydroxyquinoline (1.00 g, 6.89 mmol),
aqueous formaldehyde (38%) (0.20 g, 6.54 mmol) and MeOH
(40 mL) were placed in a 100 mL round bottom flask. The
mixture was refluxed at 75 °C for 6 h, and then cooled down.
The formed crystals were filtered from MeOH, and recrystal-
lized from 20 mL of EtOH. Yield: 0.93 g (62%); mp.:
190–192 °C. [α]20D = −1.6 (c 0.5, MeOH). The purity was ≥98%
as confirmed by NMR. For NMR peak-list see the ESI.† ESI-MS:
calc. for [H2L]
+: 307.0849 (m/z) found 307.0844 (m/z).
Synthesis of [Ru(η6-p-cym)(L)Cl]. The ligand HQCl-Pro
(5 mg, 16.3 μmol), [Ru(η6-p-cym)Cl2]2 (5.0 mg, 8.15 μmol) and
methanol (1 mL) were stirred at room temperature for 1 h, and
then the solution was concentrated. Precipitation was com-
pleted by addition of ether and cooling the mixture. The
formed solid was filtered and washed with ether and n-hexane.
Yield: 8.45 mg (89%). In NMR spectra peaks are doubled (in
2 : 1 ratio) due to the rigid structure or the existence of diaster-
eomers. For NMR peak-list see the ESI.† ESI-MS: calc. for [M
(arene)L]+: 541.0832 (m/z) found: 541.0811 (m/z) and [M(arene)
L + H]2+: 271.0455 (m/z) found: 271.0449 (m/z).
Synthesis of [Ru(η6-tol)(L)Cl]. The synthesis steps were the
same as in the case of [Ru(η6-p-cym)(L)Cl]. The amounts:
ligand HQCl-Pro (5 mg, 16.3 μmol), [Ru(η6-tol)Cl2]2 (4.3 mg,
8.15 μmol). Yield: 8.57 mg (84%). In NMR spectra peaks are
doubled (in 2 : 1 ratio) due to the rigid structure or the exist-
ence of diastereomers. For NMR peak-list see the ESI.† ESI-MS:
calc. for [M(arene)L]+: 499.0363 (m/z) found: 499.0354 (m/z)
and [M(arene)L + H]2+: 250.0221 (m/z) found: 250.0214 (m/z).
Synthesis of [Rh(η5-C5Me5)(L)Cl]. The synthesis steps were
the same as in the case of [Ru(η6-p-cym)(L)Cl]. The amounts:
ligand HQCl-Pro (5 mg, 16.3 μmol), [Rh(η5-C5Me5)Cl2]2
(5.0 mg, 8.15 μmol). Yield: 8.62 mg (90%). In NMR protons at
positions 6 and 9, in 13C NMR more peaks are doubled due to
the rigid structure or the existence of diastereomers. For NMR
peak-list see the ESI.† ESI-MS: calc. for [M(arene)L]+: 543.0922
(m/z) found: 543.0924 (m/z) and [M(arene)L + H]2+: 272.0500
(m/z) found: 272.0501 (m/z).
pH-potentiometric measurements
pH-potentiometric measurements and calculation of the
overall stability constants were performed similarly as it was
performed in our previous works (see details in the
ESI†).23,24,38–40 The computer program Hyperquad2013 46 was
utilized to establish the stoichiometry of the complexes.
UV-Vis spectrophotometric, 1H NMR and distribution coeffi-
cient measurements, and ESI-MS
An Agilent Cary 8454 diode array spectrophotometer was used
to record the UV-Vis spectra in the interval of 200–800 nm.
The path length was 0.5 or 1 cm. Only one of the proton dis-
sociation constants of HQCl-Pro could be determined by spec-
trophotometric titrations. Samples contained 130 μM HQCl-
Pro. UV-Vis spectra were used to investigate the H2O/Cl
−
exchange processes of complexes at 400 μM concentration, at
pH 5.50 (20 mM phosphate buffer) as a function of chloride
concentration (0–310 mM).
1H and 13C NMR spectroscopic studies were carried out on
a Bruker Avance III HD Ascend 500 Plus instrument. All 1H
NMR spectra were recorded with the WATERGATE water sup-
pression pulse scheme using the DSS internal standard, while
13C NMR spectra were recorded with the attached proton test
method, which shows CH and CH3 in positive mode, and C
and CH2 in negative mode. Samples were made in a 10% (v/v)
D2O/H2O mixture to yield a concentration of 300 μM and was
titrated at 25 °C, at I = 0.20 M (KNO3) in the absence or pres-
ence of [Rh(η5-C5Me5)(H2O)3]2+, [Ru(η6-p-cym)(H2O)3]2+ and
[Ru(η6-tol)(H2O)3]2+ at 1 : 1 metal-to-ligand ratio. Stability con-
stants for the complexes were calculated using the computer
program PSEQUAD.47 For characterization, 10 mM CD3OD
solutions were used.
Distribution coefficients at physiological pH (D7.4) of the
complexes and the ligand were determined by the traditional
shake-flask method in n-octanol/buffered aqueous solution at
Fig. 14 Time-dependent cellular uptake of HQCl-Pro complexes ([Ru
(η6-p-cym)(L)(H2O)]+ and [Rh(η5-C5Me5)(L)(H2O)]+) by Colo 205 cancer
cells. Checkered bars show samples without fetal bovine serum (FBS) in
medium, while striped bars show samples with FBS. Each data bar rep-
resents the mean ± standard deviation of the three parallel, separate
samples.
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pH 7.40 at various chloride concentrations using UV-Vis detec-
tion as described in our former works.23,39
ESI-MS measurements were performed using a Waters
Q-TOF Premier (Micromass MS Technologies, Manchester, UK)
mass spectrometer equipped with an electrospray ion source.
Samples contained 200 μM ligand or complex dissolved in
water, and pH was adjusted to ∼7 with a small amount of HCl
or KOH.
In vitro cell studies
Cell lines and culture conditions. Human colonic adeno-
carcinoma cell lines Colo 205 doxorubicin sensitive
(ATCC-CCL-222) and Colo 320/MDR-LRP multidrug resistant
overexpressing ABCB1 (MDR1) and LRP (ATCC-CCL-220.1)
were purchased from LGC Promochem, Teddington, UK. The
cells were cultured in RPMI 1640 medium supplemented with
10% heat-inactivated fetal bovine serum, 2 mM L-glutamine,
1 mM sodium pyruvate and 100 mM 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid (HEPES). The cell lines were incu-
bated at 37 °C, in a 5% CO2, 95% air atmosphere. The semi-
adherent human colon cancer cells were detached with
Trypsin-Versene (EDTA) solution for 5 min at 37 °C.
Assay for cytotoxicity measurement. Human colonic adeno-
carcinoma cell lines (doxorubicin-sensitive Colo 205 and multi-
drug resistant Colo 320 colonic adenocarcinoma cells) were
used to determine the effect of compounds on cell growth.
The effects of increasing concentrations of compounds (HQCl-
Pro, metal complexes, the precursor dimers [Ru/Rh(η6/5-arene)
Cl(μ-Cl)]2, doxorubicin and cisplatin) on cell growth were
tested in 96-well flat-bottomed microtiter plates. The com-
pounds were diluted in a volume of 100 μL of medium. The
density of the cells was adjusted to 2 × 104 cells in 100 μL per
well. The two-fold serial dilutions of compounds were pre-
pared in 100 μL of RPMI 1640, horizontally. The final volume
of the wells containing compounds and cells was 200 μL. The
culture plates were incubated at 37 °C for 24 h; at the end of
the incubation period, 20 μL of MTT (thiazolyl blue tetra-
zolium bromide, Sigma-Aldrich) solution (from a stock solu-
tion of 5 mg mL−1) were added to each well. After incubation
at 37 °C for 4 h, 100 μL of sodium dodecyl sulfate (SDS)
(Sigma-Aldrich) solution (10% in 0.01 M HCI) were added to
each well and the plates were further incubated at 37 °C over-
night. Cell growth was determined by measuring the optical
density (OD) at 540/630 nm with a Multiscan EX ELISA reader
(Thermo Labsystems, Cheshire, WA, USA). Inhibition of the
cell growth (expressed as IC50: the inhibitory concentration
that reduces by 50% the growth of the cells exposed to the
tested compounds) was determined from the sigmoid curve
where 100 − ((ODsample − ODmedium control)/(ODcell control −
ODmedium control)) × 100 values were plotted against the logar-
ithm of compound concentrations. Curves were fitted using
GraphPad Prism software48 using the sigmoidal dose–response
model (comparing variable and fixed slopes).
Assay for antiproliferative effect measurements. The method
is similar to that used for the cytotoxicity assay and the anti-
proliferative effect of compounds (HQCl-Pro, metal complexes,
the precursor dimers [Ru/Rh(η6/5-arene/arenyl)Cl(μ-Cl)]2, doxo-
rubicin, cisplatin) was determined. In the assay testing the
inhibition of cell proliferation, 6 × 103 colon adenocarcinoma
cells were distributed in 100 μL of medium with the exception
of the medium control wells. The culture plates were incubated
at 37 °C for 72 h and after the incubation time the plates were
stained with MTT according to the experimental protocol
applied for the cytotoxicity assay vide supra.
Cellular uptake measurements. For accumulation studies,
Colo 205 adenocarcinoma cells were grown in 75 cm2 culture
flasks (Sarstedt) in order to get a monolayer. The cells were
trypsinized and harvested and 106 cells in 1 mL of RPMI
1640 medium were distributed into 24-well plates, seeded and
incubated overnight at 37 °C in a CO2 incubator. On the fol-
lowing day, the medium was removed and fresh medium was
added to the samples containing either the Rh-complex or the
Ru-complex; furthermore the effect of fetal bovine serum (FBS)
was also checked: half of the samples were incubated without
FBS, and the other half were incubated in the presence of it.
All samples were triplicated under each condition. At appropri-
ate time points (4 h and 24 h of incubation) the flasks were
taken out from the incubator for Rh and Ru measurements,
and the cells were harvested with a trypsin solution after incu-
bation. Trypsinization was stopped with complete RPMI
1640 medium and then, the cells were washed twice with 1 mL
phosphate-buffered saline (PBS). The cells were subjected to
an acidic microdigestion method.
Samples were analyzed by TXRF spectrometry; a TXRF
8030C spectrometer (Atomika Instruments GmbH,
Oberschleissheim, Germany), equipped with a 3 kW fine focus
X-ray tube containing a Mo/W alloy anode, a W/C multi-layer
monochromator, adjusted to obtain an excitation energy of 33
keV selected out from the Bremsstrahlung was used. A Si(Li)
detector with an active area of 80 mm2 was in operation with a
resolution of 150 eV at 5.9 keV. 10 μL of 100 mg L−1 Ga was
added to the samples prior to the TXRF analysis as the internal
standard for the quantification procedure. Rh and Ru were not
detected in blank samples. Due to the imprecision of cell
counting, the Rh results were normalized to the Zn or S
content of the samples.
Conclusions
A novel 8-hydroxyquinoline hybrid, (S)-5-chloro-7-((pro-line-1-
yl)methyl)8-hydroxyquinoline (HQCl-Pro) was designed and
prepared possessing excellent water solubility compared to the
poorly soluble 8-hydroxyquinoline. HQCl-Pro harbors a CH2–N
building block at position 7 that often has a role in MDR rever-
sal activity, and as a bidentate ligand bearing an (N,O) donor it
is an efficient chelator for half-sandwich organometallic Ru(II)
and Rh(III) triaqua cations. Herein complex formation equili-
bria of HQCl-Pro with [Rh(η5-C5Me5)(H2O)3]2+, [Ru(η6-p-cym)
(H2O)3]
2+ and [Ru(η6-tol)(H2O)3]2+ were investigated in chlor-
ide-free aqueous solutions by pH-potentiometry, UV-visible
spectrometry and 1H NMR spectroscopy. Stability and proton
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dissociation constants of the [M(arene)(L)(H2O)]
+ complexes in
addition to H2O/Cl
− co-ligand exchange constants were deter-
mined. HQCl-Pro forms complexes with high but slightly lower
stability compared with the unsubstituted 8-hydroxyquinoline.
Arene loss and the oxidation of Ru(II) were found as side reac-
tions with ligand excess at physiological pH. The excess of
HQCl-Pro or rigid aromatic (N,N) bidentate ligands reacted
with [Ru(η6-p-cym)(L)(H2O)]+ causing loss of p-cymene followed
by oxidation or binding of a third bidentate ligand. Reaction
did not occur with deferiprone containing oxygen donor
atoms. The reactions with ethylenediamine, HSA, histidine
and RPMI 1640 components were similar: most probably the
formation of the mixed-ligand complex occurred without oxi-
dation or p-cymene loss.
Formation of mixed hydroxido [M(arene)(L)(OH)] complexes
is less than 10% at physiological pH in the absence of chloride
ions, and it is assumed to be an even lower fraction in the
presence of this coordinating co-ligand. Substitution of the co-
ordinated water molecule in the complex [M(arene)(L)(H2O)]
+
by chloride ions results in neutral complexes, which have
much higher lipophilicity than the aqua form and the ligand
itself. The Rh(η5-C5Me5) complex has stronger chloride ion
affinity than the Ru(η6-arene) containing ones, and the Ru(η6-
tol) complex was found to be the most hydrophilic among the
studied compounds.
The in vitro cytotoxic and antiproliferative activity of HQCl-
Pro and its half-sandwich organometallic complexes were
studied in Colo 205 drug sensitive and Colo 320 multidrug
resistant cancer cell lines by the MTT assay in addition to cel-
lular metal uptake studies. HQCl-Pro and its [Rh(η5-C5Me5)(L)
(H2O)]
+ complex showed relatively strong anticancer activity
and moderate MDR selectivity, while complexation with ruthe-
nium–arene species results in a lower or similar activity in the
Colo 320 cell lines compared to that obtained in Colo 205
cells. Based on the 1H NMR spectra recorded for the Ru(η6-p-
cym) complex of HQCl-Pro in the cell medium RPMI 1640 it
was concluded that only mixed-ligand complex formation
occurred with histidine, and the bidentate ligand is not disso-
ciated from the complex. While a similar metal uptake level
was found for both the Rh(η5-C5Me5) and Ru(η6-p-cymene)
complexes using a 4 h incubation period, the longer incu-
bation led to a higher intracellular Rh content which might
contribute to the lower IC50 values of the Rh(η5-C5Me5)
complex.
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